文献速递卫生政策与健康促进免疫规划

寻找平衡:流行病防范创新联盟修订其公平可及政策

Finding equipoise: CEPI revises its equitable access policy.
PubMed 文献 · Vaccine · 2020-01-28

流行病防范创新联盟(CEPI)是由公共、私营、慈善和民间组织组成的创新伙伴关系,旨在激励、资助和协调市场激励失效时针对流行潜力疾病的疫苗开发。本文描述了修订其公平可及政策的过程及关键问题的解决方式,CEPI将继续采取迭代而非规定性的方法。

要点

  • CEPI是由公共、私营、慈善和民间组织组成的创新伙伴关系,使命是激励、资助和协调市场激励失效时针对流行潜力疾病的疫苗开发。
  • CEPI将继续采取迭代而非规定性的方法制定政策,以反映多方利益相关者的需求并确保实现其公平可及目标。

核心结论

  • CEPI将继续采取迭代而非规定性的方法制定其公平可及政策,以反映多方利益相关者的需求并确保实现其公平可及目标。

研究设计与样本

  • 本文描述了CEPI修订其公平可及政策的过程及关键问题的解决方式。

主要发现

  • CEPI于2017年1月在达沃斯启动,由主权投资者和慈善机构资助。
  • 投资包括针对优先病原体(拉沙热病毒、中东呼吸综合征冠状病毒、尼帕病毒、基孔肯雅热、裂谷热)的19个疫苗候选和三个针对疾病X的疫苗平台。
  • CEPI在成立后不久制定了初步公平可及政策,关键利益相关者对其内容和规定性表达了强烈意见。
  • CEPI董事会指示一年后重新审视该政策。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Launched at Davos in January 2017 with funding from sovereign investors and philanthropic institutions, the Coalition for Epidemic Preparedness Innovations (CEPI) is an innovative partnership between public, private, philanthropic, and civil organisations whose mission is to stimulate, finance and co-ordinate vaccine development against diseases with epidemic potential in cases where market incentives fail. As of December 2019, CEPI has committed to investing up to $706 million in vaccine development. This includes 19 vaccine candidates against its priority pathogens (Lassa fever virus, Middle East respiratory syndrome coronavirus, Nipah virus, Chikungunya, Rift Valley fever) and three vaccine platforms to develop vaccines against Disease X, a novel or unanticipated pathogen. As an entity largely supported by public funds, ensuring equitable access to vaccines whose development it supports in low- and middle-income countries is CEPI's primary focus. CEPI developed an initial equitable access policy shortly after its formation, with key stakeholders expressing strong views about its content and prescriptive nature. The CEPI board instructed that it be revisited after a year. This paper describes the process of revising the policy, and how key issues were resolved. CEPI will continue to take an iterative, rather than prescriptive, approach to its policy-one that reflects the needs of multiple stakeholders and ensures it can meet its equitable access goals.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Huneycutt B, Lurie N, Rotenberg S, et al. Finding equipoise: CEPI revises its equitable access policy. Vaccine. 2020. PMID: 32005536. doi:10.1016/j.vaccine.2019.12.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。